Introducing the... BD Instrument Company Liaison Initiative
Navigating today’s complex clinical landscape by Fostering an Even Higher Level of Communication with Our Instrument Company Partners
In helping you to navigate today’s complex clinical landscape, BD has formed a cross-functional Instrument Company Liaison (ICL) Team, whose focus is to establish and foster instrument company collaborations and programs on all key functional levels. The ICL Team is comprised of Key Account Managers, PhD Clinical Scientists, dedicated Marketing Professionals, and Project Engineers.
|
Key capabilities include:
- Establishing and fostering collaborative development initiatives between BD and Instrument Companies
- Driving resolution of system-related issues and opportunities through dialogue and decision
- Serving as the voice of the customer and marketing bi-directionally to BD and Instrument Companies
- Conducting market sensing and monitoring activities and sharing results
- Communicating and supporting the value and brand of both BD and Instrument Companies
|
|
Working relationships between BD and the instrument companies will continue to benefit laboratories – as they have done most recently in identifying the root cause of immunoassay interference – by creating practical solutions to ensure quality, accuracy, and consistency in diagnostic testing.
|
 |
|
IN THIS ISSUE
|
|
![[spacer image]](/images/shadow_top_left.gif){kind=small}
United States
![[spacer image]](/images/spacer.gif){kind=small}
![[spacer image]](/images/spacer_white.gif){kind=small}
![[spacer image]](/images/spacer_gray.gif){kind=small}
![[spacer image]](/images/shadow_top_right.gif){kind=small}
![[spacer image]](/images/shadow_left.gif){kind=small}
![[spacer image]](/images/spacer_blue.gif){kind=small}
![[spacer image]](/images/shadow_right.gif){kind=small}
![[spacer image]](/images/shadow_bottom_left.gif){kind=small}
![[spacer image]](/images/shadow_bottom.gif){kind=small}
![[spacer image]](/images/shadow_bottom_right.gif){kind=small}